Modulation of Fas receptor proteins and dynamin during opiate addiction and induction of opiate withdrawal in rat brain.

scientific article published on 3 October 2003

Modulation of Fas receptor proteins and dynamin during opiate addiction and induction of opiate withdrawal in rat brain. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00210-003-0801-9
P698PubMed publication ID14530904

P50authorAntonio MirallesQ42793775
M. Julia García-FusterQ60313486
P2093author name stringJesús A García-Sevilla
Marcel Ferrer-Alcón
P2860cites workA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingQ25938984
Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigenQ28115556
The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunityQ28139188
CD95's deadly mission in the immune systemQ28142072
The Fas signaling pathway: more than a paradigmQ28201953
Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brainQ28363748
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosisQ29618601
The Fas death factorQ29620461
Dynamin, endocytosis and intracellular signalling (review).Q30176794
The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigenQ30988634
Early alterations of actin cytoskeleton in OK cells by opioids.Q32060677
Apoptosis and the nervous systemQ33806940
Structure and function of Fas/Fas ligandQ33811723
Fas ligand-induced apoptosisQ33847658
Apoptosis in the nervous systemQ34068965
TNF ligands and receptors--a matter of life and deathQ34542205
Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.Q34727185
Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expressionQ36368408
Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overloadQ39737479
Role of p38 mitogen-activated protein kinase phosphorylation and Fas-Fas ligand interaction in morphine-induced macrophage apoptosis.Q40739727
Dissociation of functional roles of dynamin in receptor-mediated endocytosis and mitogenic signal transductionQ40934310
Phosphorylation is not required for dynamin-dependent endocytosis of a truncated mutant opioid receptorQ41008868
Molecular cloning and pharmacological characterization of the rat sigma1 receptorQ43659980
Sigma1 receptor modulation of opioid analgesia in the mouseQ43893570
Mu-opioid receptor mediates chronic restraint stress-induced lymphocyte apoptosisQ44147207
Overexpression of dynamin is induced by chronic stimulation of mu- but not delta-opioid receptors: relationships with mu-related morphine dependenceQ44332011
The Fas/FasL apoptotic pathway is involved in kappa-opioid-induced apoptosis of human endometrial stromal cellsQ44336321
Antagonist-induced micro-opioid receptor up-regulation decreases G-protein receptor kinase-2 and dynamin-2 abundance in mouse spinal cordQ44338806
Downregulation of neuronal cdk5/p35 in opioid addicts and opiate-treated rats: relation to neurofilament phosphorylationQ44340809
A human neuroblastoma cell line expresses mu and delta opioid receptor sites.Q44346540
Effects of heroin and its metabolites on schedule-controlled responding and thermal nociception in rhesus monkeys: sensitivity to antagonism by quadazocine, naltrindole and beta-funaltrexamineQ44394303
Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female ratsQ44448613
Novel sigma receptor ligands attenuate the locomotor stimulatory effects of cocaineQ46887506
FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrierQ48166557
The alkylating agent EEDQ facilitates protease-mediated degradation of the human brain alpha2A-adrenoceptor as revealed by a sequence-specific antibodyQ48230536
Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gammaQ48286191
Marked decrease of immunolabelled 68 kDa neurofilament (NF-L) proteins in brains of opiate addictsQ48708352
Modulation of immunoreactive protein kinase C-alpha and beta isoforms and G proteins by acute and chronic treatments with morphine and other opiate drugs in rat brainQ48745950
Staurosporine- and H-7-induced cell death in SH-SY5Y neuroblastoma cells is associated with caspase-2 and caspase-3 activation, but not with activation of the FAS/FAS-L-caspase-8 signaling pathwayQ49106082
Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations.Q52114306
Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1.Q52534596
Fas-mediated cell death promoted by opioidsQ59098772
A proposal for the classification of sigma binding sitesQ67487993
Involvement of sigma 1 receptor in (+)-N-allylnormetazocine-stimulated hippocampal cholinergic functions in ratsQ70822011
Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liverQ71794021
Spontaneous withdrawal from long-term treatment with morphine accelerates the turnover of alpha 2-adrenoceptors in the rat brain: up-regulation of receptors associated with increased receptor appearanceQ72261195
Activation-induced aggregation and processing of the human Fas antigen. Detection with cytoplasmic domain-specific antibodiesQ73618030
Cutting edge: a novel role for Fas ligand in facilitating antigen acquisition by dendritic cellsQ74650416
Fas engagement induces neurite growth through ERK activation and p35 upregulationQ78836977
P433issue5
P921main subjectopioid use disorderQ1639178
P304page(s)421-431
P577publication date2003-10-03
P1433published inNaunyn-Schmiedeberg's Archives of PharmacologyQ1468251
P1476titleModulation of Fas receptor proteins and dynamin during opiate addiction and induction of opiate withdrawal in rat brain
P478volume368

Reverse relations

cites work (P2860)
Q43003226Cerebellar neuronal apoptosis in heroin-addicted rats and its molecular mechanism.
Q36205750Cerebellum Transcriptome of Mice Bred for High Voluntary Activity Offers Insights into Locomotor Control and Reward-Dependent Behaviors
Q35764822Chronic Opium Treatment Can Differentially Induce Brain and Liver Cells Apoptosis in Diabetic and Non-diabetic Male and Female Rats
Q48228685Chronic methadone treatment and repeated withdrawal impair cognition and increase the expression of apoptosis-related proteins in mouse brain.
Q45851009Chronic treatment with selective I2-imidazoline receptor ligands decreases the content of pro-apoptotic markers in rat brain
Q38527077Decreased proliferation of adult hippocampal stem cells during cocaine withdrawal: possible role of the cell fate regulator FADD.
Q34528040Distinctive profiles of gene expression in the human nucleus accumbens associated with cocaine and heroin abuse
Q28574580Effect of cocaine on Fas-associated protein with death domain in the rat brain: individual differences in a model of differential vulnerability to drug abuse
Q46947457Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspases in the rat brain: regulation by the ERK1/2 MAP kinase pathway.
Q30454318Genes and pathways co-associated with the exposure to multiple drugs of abuse, including alcohol, amphetamine/methamphetamine, cocaine, marijuana, morphine, and/or nicotine: a review of proteomics analyses
Q33803552Ovary cells apoptosis in opium-addicted diabetic and non-diabetic rats.
Q37343024Persistent proteomic alterations in the medial prefrontal cortex with abstinence from cocaine self-administration
Q39280116Pro-apoptotic properties of morphine in neuroblastoma × glioma NG108-15 hybrid cells: modulation by yohimbine
Q48337573Regulation of cannabinoid CB2 receptor constitutive activity in vivo: repeated treatments with inverse agonists reverse the acute activation of JNK and associated apoptotic signaling in mouse brain

Search more.